Amy Parison serves as Executive at Editas Medicine, Inc., where they oversee executive responsibilities. Since joining the company, Amy Parison has executed 3 insider transactions totaling $3.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 3, 2025 involved selling 461 shares valued at $991.
Amy Parison currently holds 15,908 shares of Editas Medicine, Inc. (EDIT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amy Parison has been a net seller of EDIT stock. They have purchased $0 and sold $3.9K worth of shares.
Amy Parison's most recent insider trade was on Dec 3, 2025, when they sold 461 shares at $2.15 per share.
Get notified when new Form 4 filings are submitted
| $2.60 |
| Discretionary |
| Aug 7, 2025 | EDIT | $1.8K | Sale | 679 | $2.58 | Discretionary |